This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ruprecht-Karls-Universitat Heidelberg. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Vasileios Askoxylakis: Innovator in Liver-Specific Diagnostics
Introduction
Vasileios Askoxylakis is a notable inventor based in Wilhelmsfeld, Germany. He has made significant contributions to the field of medical diagnostics, particularly in liver-specific applications. His innovative work has led to the development of a unique patent that addresses critical needs in liver disease diagnosis.
Latest Patents
Vasileios Askoxylakis holds a patent for "Hydrophobic modified peptides for liver specific diagnosis." This invention relates to hydrophobic modified peptides designed for the specific delivery of labels to the liver, particularly targeting hepatocytes, both in vitro and in vivo. The patent encompasses pharmaceutical compositions that include these hydrophobic modified peptides and the labels intended for liver delivery. Furthermore, it outlines the diagnostic applications of these peptides and methods for diagnosing liver diseases or disorders.
Career Highlights
Throughout his career, Vasileios has worked with esteemed institutions such as Ruprecht-Karls-Universität Heidelberg and the Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Walter Mier and Stephan Urban. Their collaborative efforts have further advanced the research and development of innovative diagnostic methods.
Conclusion
Vasileios Askoxylakis is a prominent figure in the realm of liver diagnostics, with a patent that showcases his innovative approach to medical challenges. His contributions continue to impact the field positively, paving the way for advancements in liver disease diagnosis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
